SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-016983
Filing Date
2019-03-05
Accepted
2019-03-05 18:30:35
Documents
1
Period of Report
2019-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3862
  Complete submission text file 0001209191-19-016983.txt   5247
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Issuer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Moriarty John B (Reporting) CIK: 0001564621 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35935 | Film No.: 19660389